| Patent application number | Description | Published |
|---|
| 20080312736 | IMPLANT HAVING A SURFACE-PROXIMAL MAGNESIUM-CONTAINING DIFFUSION LAYER AND ASSOCIATED PRODUCTION METHOD - An implant comprising an implant material forming a base made of one or more metallic elements; a diffusion layer covering the base made of at least one of the metallic elements of the implant material and at least magnesium; and, optionally, a metal layer covering the diffusion layer made of magnesium or a biocorrodible magnesium alloy. | 12-18-2008 |
| 20090069884 | STENT HAVING A BASE BODY OF A BIOCORRODABLE ALLOY - A stent comprising a base body consisting at least in part of either an arsenic-containing or selenium-containing biocorrodable alloy of at least one element selected from the group consisting of magnesium, iron, tungsten, zinc and molybdenum. A method for producing a stent with a base body having a core and a diffusion layer covering the core and an arsenic-containing and/or selenium-containing biocorrodable alloy comprising at least one element selected from the group consisting of magnesium, iron, tungsten, zinc and molybdenum. | 03-12-2009 |
| 20090198320 | IMPLANT WITH A BASE BODY OF A BIOCORRODIBLE IRON ALLOY - An implant having a base body comprising entirely or in part a biocorrodible iron alloy wherein the base body of the implant comprises at least one of the following: (i) a biocorrodible iron alloy of formula (1): Fe—P where the amount of P in the alloy is from 0.01 to 5 wt %, and Fe plus impurities due to the production process account for the remainder of the alloy up to 100 wt %; or (ii) a biocorrodible iron alloy of the formula (2): Fe—Mn—X where the amount of Mn in the alloy is from 5 to 30 wt %, X stands for one or more elements selected from the group consisting of Pt, Pd, Ir, Rh, Re, Ru and Os, and the amount of X in the alloy is from 0 to 20 wt % and Fe plus impurities due to the production process account for the remainder of the alloy up to 100 wt %; or (iii) a biocorrodible iron alloy of formula (3): Fe-Z where Z is one or more elements selected from the group consisting of Pt, Ir and Os and the amount of Z in the alloy is from 5 to 30 wt %, and Fe plus impurities due to the production process account for the remainder of the alloy up to 100 wt %. | 08-06-2009 |
| 20090208555 | CONTROL OF THE DEGRADATION OF BIODEGRADABLE IMPLANTS USING A COATING - The invention relates to an endovascular implant, which is at least largely biodegradable and whose in vivo degradation can be controlled. To achieve this, the implant comprises a tubular base body, open on its end faces and consisting of at least one biodegradable material, said base body having an in vivo, location-dependent first degradation characteristic D | 08-20-2009 |
| 20100249900 | Drug eluting medical implant with porous surface - An implant is proposed, in particular made from a base material including a biodegradable metal and/or a biodegradable metal alloy, wherein the implant includes a coating made of crystalline calcium phosphate and/or amorphous calcium phosphate. | 09-30-2010 |
| 20110144761 | BIOCORRODIBLE IMPLANT HAVING A CORROSION-INHIBITING COATING - One embodiment of the invention relates to a biocorrodible implant based on magnesium or a biocorrodible magnesium alloy, whose surface has a corrosion-inhibiting coating. Furthermore, other invention embodiments relate to a respective manufacturing method for the coating. According to an invention embodiment, an implant is provided, comprising | 06-16-2011 |
